Background Androgens are involved in the development of prostate cancer. Finasteride, an
inhibitor of 5α-reductase, inhibits the conversion of testosterone to dihydrotestosterone, the …

Background The optimal upper limit of the normal range for prostate-specific antigen (PSA)
is unknown. We investigated the prevalence of prostate cancer among men in the Prostate …

Context Secondary analyses of 2 randomized controlled trials and supportive epidemiologic
and preclinical data indicated the potential of selenium and vitamin E for preventing …

Twelve hundred ninety-six patients with resected colon cancer that either was locally invasive
(Stage B 2 ) or had regional nodal involvement (Stage C) were randomly assigned to …

Context The initial report of the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
found no reduction in risk of prostate cancer with either selenium or vitamin E supplements …

To test the hypothesis that maximal androgen blockade improves the effectiveness of the
treatment of prostatic cancer, we conducted a randomized, double-blind trial in patients with …

ContextThe risk factors for cardiovascular disease and erectile dysfunction are similar.ObjectiveTo
examine the association of erectile dysfunction and subsequent cardiovascular …

Background: Prostate-specific antigen (PSA) testing is the primary method used to diagnose
prostate cancer in the United States. Methods to integrate other risk factors associated with …

ContextThree fourths of US men older than 50 years have been screened with prostate-specific
antigen (PSA) for prostate cancer.ObjectiveTo estimate the receiver operating …

Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified
more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data …